App-Quantinova.ai

SPIRONOLACTONE THERAPY FOR CARDIOMYOPATHY IN DUCHENNE MUSCULAR DYSTROPHY

Michelle Ploutza - American College of Cardiology (ACC) , 2017

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

N/A

Spironolactone

CYSTATIN C IS ASSOCIATED WITH THE RISK OF ADVERSE OUTCOMES INDEPENDENT OF ESTABLISHED AND NOVEL CARDIORENAL MARKERS: AN ANALYSIS FROM THE SOLID-TIMI 52 TRIAL

Simon Correa Gaviria - American College of Cardiology (ACC) , 2017

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

N/A

Darapladib

IMPACT OF BODY MASS INDEX ON PROGNOSTIC PREDICTION BY CREATININE-BASED ESTIMATED GLOMERULAR FILTRATION RATE AND CYSTATIN C IN HEART FAILURE

Yuya Matsue - American College of Cardiology (ACC) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Congestive heart failure

N/A

INTERMEDIATE RISK PATIENTS WITH RENAL INSUFFICIENCY HAVE MORE CALCIFIED CORONARY ARTERY LESIONS, MORE DISTAL LESION DISTRIBUTIONS, AND LONGER/WIDER LESION GEOMETRIES BY LESION SPECIFIC CALCIUM SCORING

Wassim Mohammed Odeh - American College of Cardiology (ACC) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Complex calcified coronary artery lesions

N/A

CYSTATIN C: A NOVEL BIOMARKER FOR PULMONARY ARTERIAL HYPERTENSION

Brett Fenster - American College of Cardiology (ACC) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Pulmonary arterial hypertension

N/A

ASSOCIATION OF CYSTATIN C WITH MEASURES OF OBESITY AND ITS IMPACT ON CARDIOVASCULAR EVENTS AMONG HEALTHY U.S. ADULTS

Sidak Panaich - American College of Cardiology (ACC) , 2013

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Coronary Artery Disease

N/A

Renal resistive indices, urinary albumin excretion and renal function in patients with resistant hypertension after catheter-based renal sympathetic denervation

Felix Mahfoud - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Hypertension

N/A

Prediction of lesion type related MACE by sFLT-1 and GDF-15. Results from The PROSPECT study

Martin Mockel - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Acute Coronary Syndromes

N/A

Effect of Smoking on Clinical Characteristics and Prognosis of patients with ACS

Yao Zhuhua - Great Wall International Congress of Cardiology (GWICC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Acute Coronary Syndromes

Grace

Relativity Analysis on Cystatin C and vulnerable plaque of coronary artery disease

Gu Yunfei - Great Wall International Congress of Cardiology (GWICC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

N/A

Cystatin C combined with creatinine seems to be a reliable early predictor of MACEs in patients undergoing PCI

Zhang Weifeng - Great Wall International Congress of Cardiology (GWICC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Contrast-induced Acute Kidney Injury

N/A

Serum Cystatin C Level Not Associated with Coronary Artery Plaque Vulnerability Analyzed by Optical Coherence Tomography

Jin Qinhua - Great Wall International Congress of Cardiology (GWICC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

N/A

Cystatin C combined with creatinine seems to be a better early predictor of CI-AKI in patients undergoing PCI

Shen Linghong - Great Wall International Congress of Cardiology (GWICC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Contrast-induced Acute Kidney Injury

N/A

Impact of recombinant brain natriuretic peptide for prevention of contrast-induced nephropathy in patients with chronic kidney disease undergoing non-emergent percutaneous coronary intervention or coronary angiography

Liu Jinming - Great Wall International Congress of Cardiology (GWICC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Contrast-induced Acute Kidney Injury

rhBNP

The Correlation Analysis between plasma Cystatin C and the prognosis of patients with STEMI

Pei Sun - Great Wall International Congress of Cardiology (GWICC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial infarction

N/A

Serum Cystatin C as a Potential Predictor for the Progression of Prehypertension-to-hypertension

Ruimin Dong - Great Wall International Congress of Cardiology (GWICC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Hypertension

N/A

Morning Blood Pressure Surge is Associated with Cystatin C in Essential Hypertensive Patients

Dengfeng Gao - Great Wall International Congress of Cardiology (GWICC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Renal disease

N/A

Cystatin C is Associated with Cardiovascular Autonomic Neuropathy in Newly Diagnosed Type 2 Diabetic Patients

Xubin Yang - Great Wall International Congress of Cardiology (GWICC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Diabetic neuropathy

N/A

SERUM CREATININE IN FEMALE PATIENTS WITH CIRRHOSIS UNFAIRLY BIAS LIVER TRANSPLANT WAIT LIST RANKING: IMPLICATIONS FOR ELIMINATION OF GENDER DISPARITIES IN ACCESS TO ORTHOTOPIC LIVER TRANSPLANTATION

Antone R. Opekun - Digestive Disease Week (DDW) , 2017

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

N/A

Arginine hydrochloride

DELAYED REDUCTION IN CYSTATIN C-BASED GFR AFTER PCI IS A PREDICTOR OF ADVERSE OUTCOMES IN PATIENTS WITH PRESERVED RENAL FUNCTION

H.B. Park - World Congress on Heart Disease , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Myocardial infarction

N/A

Filters

169 Abstracts